PharmaShots Weekly Snapshot (November 16-20, 2020)
Published: Nov 20,2020 | Tags: baricitinib, COVID-19, Eli Lilly, Emergency Use Authorization, FDA's, Incyte, receives, Remdesivir
Published: Nov 20,2020 | Tags: Agreement, ARDS, Commercialize, Develop, Manufacture, Mesoblast, Novartis, Remestemcel-L, Signs, Treatment
Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)
Published: Nov 20,2020 | Tags: (adalimumab), Alvotech, AVT-301 Study, AVT-GL-101, AVT02, Chronic Plaque Psoriasis, EMA, Humira, Proposed Biosimilar, Regulatory Applications, Submits, Us FDA
Published: Nov 20, 2020 | Tags: Lilly, Signs, Agreement, Ypsomed, Advance, Automated Insulin Delivery System, People, Diabetes
Pfizer And LianBio Collaborate to Expand the Development of Novel Therapeutics in Greater China
Published: Nov 20, 2020 | Tags: Pfizer, LianBio, Collaborate, Expand, Development, Novel Therapeutics, Greater China
AstraZenca's Imfinzi (durvalumab) Receives the US FDA's Approval for Less-Frequent Fixed-Dose Use
Published: Nov 20,2020 | Tags: AstraZenca, CASPIAN Study, durvalumab, Imfinzi, P-lll, PACIFIC, US FDAs
Chiesi's Bronchitol (mannitol) Inhalation Powder Receives the US FDA's Approval for Cystic Fibrosis
Published: Nov 19, 2020 | Tags: approval, Bronchitol, Chiesi, Cystic Fibrosis, Inhalation, Mannitol, Powder, Pulmonary, receives, US FDA
Published: Nov 19, 2020 | Tags: Authorization, COVID-19, First, Home, Lucira, Lucira Health, Molecular, Prescription, receives, Test, Us FDA
Bayer to Fund Five New Startup Companies as Part of G4A Digital Health Partnerships Program
Published: Nov 19, 2020 | Tags: Bayer, Collaborate, Developed, G4A Digital Health, Healthcare Solutions, Integrated
ViiV's PROgress Study Demonstrates Inclusion of PROs into Clinical Practice Can Improve HIV Care
Published: Nov 19, 2020 | Tags: Progress, reports, results, study, ViiV Healthcare
Pear Therapeutics Launches Somryst Insomnia App Via an End-to-End Virtual Care Experience
Published: Nov 19, 2020 | Tags: Chronic Insomnia, Launches, Pear Therapeutics, Somryst
Pfizer and BioNTech's BNT162b2 Demonstrates 95% Efficacy in Preventing COVID-19
Published: Nov 19, 2020 | Tags: 95%, BioNTech, BNT162b2, COVID-19, Demonstrates, Efficacy, Pfizer, Preventing
Published: Nov 19, 2020 | Tags: EC's, Influenza, Marketing Authorization, patients, quadrivalent recombinant influenza vaccine, receives, Sanofi, Supemtek
Published: Nov 18,2020 | Tags: Acceptance, Biogen, Biosimilar, FDA Filing, Lucentis, ranibizumab, Retinal Vascular Disorders, Samsung Bioepis, SB11
Published: Nov 18, 2020 | Tags: Advancing, Agreement, Artificial Intelligence, BioMarin Pharmaceutical, Deep Genomics, Identified, Programs, Signs, Using
Pfizer Launches US Pilot Programme for Delivery and Distribution of COVID-19 Vaccine, BNT162b2
Published: Nov 18, 2020 | Tags: 4, COVID-19, Delivery, Deployment, Immunization, Pfizer, Pilot, Program, states, Updates, US,
Published: Nov 18, 2020 | Tags: Avalglucosidase-alfa, BLA, Enzyme Replacement Therapy, Pompe disease, Priority Review, receives, Sanofi, US, FDA
ViiV Healthcare's Cabotegravir Receives US FDA's Breakthrough Therapy Designation for HIV Prevention
Published: Nov 18,2020 | Tags: Breakthrough, Cabotegravir, Designation, HIV, receives, therapy, Us FDA, ViiV Healthcare
Published: Nov 18,2020 | Tags: BAY 94-8862, Bayer, Cardiovascular Disease, Chronic Kidney Disease, FIDELIO-DKD Study, Finerenone, Inflammatory, Type 2 Diabetes
Published: Nov 17, 2020 | Tags: (tigilanol tiglate injection), Non-Metastatic Mast Cell Tumors, QBiotics Group, receives, Stelfonta, US FDA's Approval
Johnson & Johnson Initiates Second Global P-III Study of its COVID-19 Vaccine
Published: Nov 17, 2020 | Tags: COVID-19, ENSEMBLE, ENSEMBLE-2 Study, Initiates, Johnson & Johnson, P-lll
Published: Nov 17,2020 | Tags: Develop, Immune Mediated Diseases, Lead Pharma, License Agreement, Research Collaboration, Roche, Signs, Small Oral Molecules
Published: Nov 17,2020 | Tags: Advanced, ALX Oncology, ALX148, Breast Cancer, Collaborate, Evaluate, HER2-Expressing, Zanidatamab, Zymeworks
Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19
Published: Nov 17, 2020 | Tags: COVE Study, COVID-19, Interim Analysis, Moderna, mRNA-1273, P-lll, reports, results
Bharat Biotech Initiates P-III Study for Covaxin Against COVID-19
Published: Nov 17,2020 | Tags: Against, Bharat Biotech, Covaxin, COVID-19, Initiates, P-III, study
Microsoft Collaborates with Twist and Illumina to Advance Data Storage in DNA
Published: Nov 16, 2020 | Tags: advance, Collaborates, Data Storage, DNA, Illumina, Microsoft, Twist
J&J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development
Published: Nov 16, 2020 | Tags: Agreement, Candidate, Covid-19 Vaccine, Development, Expand, J&J, U.S. Department of Health & Human Services
Published: Nov 16, 2020 | Tags: Eisai's, EU's Approval, Fycompa, perampanel, PGTCS, POS, receives
Roche's Xofluza (baloxavir marboxil) Receives CHMP's Recommendation for Approval to Treat Influenza
Published: Nov 16, 2020 | Tags: baloxavir marboxil, EU's Approval, Influenza, receives, Roche, Xofluza
Eli Lilly Signs a License Agreement with Seed Therapeutics for Protein Degradation-Based Therapies
Published: Nov 16, 2020 | Tags: Eli Lilly, License Agreement, Protein Degradation-Based Therapies, Seed Therapeutics, Signs
Henlius Report the NMPA's Acceptance of HLX15 (biosimilar, Daratumumab) to Treat Multiple Myeloma
Published: Nov 16, 2020 | Tags: (biosimilar, Acceptance, daratumumab, Henlius, HLX15, Multiple Myeloma, NMPA, Report, Treat
Related Post: PharmaShots Weekly Snapshots (Nov 09-13, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com